Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome

BACKGROUND: Oral tacrolimus is a therapeutic agent for moderate to severe steroid-dependent or resistant ulcerative colitis (UC), but remission induction is difficult, and it is necessary to treat the patient while considering the next treatment. AIM: To examine serum albumin (Alb) level as a progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishida, Natsuki, Miyazu, Takahiro, Tamura, Satoshi, Tani, Shinya, Yamade, Mihoko, Iwaizumi, Moriya, Hamaya, Yasushi, Osawa, Satoshi, Furuta, Takahisa, Sugimoto, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192282/
https://www.ncbi.nlm.nih.gov/pubmed/34168412
http://dx.doi.org/10.3748/wjg.v27.i22.3109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192282/
https://www.ncbi.nlm.nih.gov/pubmed/34168412
http://dx.doi.org/10.3748/wjg.v27.i22.3109

Ejemplares similares